$QNTA Green up @ 0.0098 +22.5000% The Company plans to further investigate the effectiveness of the polarization technology in different applications of pain relief, chemotherapy, ribosome-based drug development, and more. Medolife also conducted studies testing the efficacy of polarized CBD, polarized Ibuprofen, the Company’s lead drug candidate Escozine®, and more. The results further suggest the success in which the polarization process increases the potency of active pharmaceutical ingredients (APIs).
(0)
(0)